InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
Provided By GlobeNewswire
Last update: Oct 21, 2025
JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference. Details are as follows:
Read more at globenewswire.com
